Intellia Therapeutics Was a Winner on Wednesday, according to the Motley Fool Intellia Therapeutics (NASDAQ: NTLA) had another strong day on Wednesday, only days after experiencing a significant stock price increase. “We intend to use the net proceeds from this offering to advance the clinical development of our lead programs, other pipeline candidates, and continued investment in our modular platform, as well as for working capital, and other general corporate purposes,” the company wrote in a regulatory filing. It had roughly the same amount of cash, equivalents, and marketable securities on its books at the end of March./n
Read More
